I work as a stroke physician at Department of Neurology at Aarhus University Hospital. My research interest is mainly on prehospital triage of patients with acute stroke. Also, I am interested in peri-procedual management of endovascular therapy.
Our goal is to study neuroprotection methods and improve prehospital organization and acute revascularization treatment leading to better life after stroke. Our research group build on a strong and well-established cross-disciplinary collaboration.
My research group works on the mechanisms of ALS, polyneuropathy and criticial illness myopathy, and earlier diagnosis of these using novel methods. We are pionering the development and implementation of cortical excitability testing with TMS, muscle/nerve excitability testing and MScanFit MUNE.
We trace uncertainties of prognostics and decision making in unresponsive patients with serious brain injury between scientific and clinical reasoning. Studying knowledge relationality in an interdisciplinary team with outset in anthropology and medical humanities. See also: bit.ly/3cxUyiL.
The research goal of my team is to use different types of brain scans and other advanced neuroimaging techniques to understand the brain changes occurring in Parkinson’s and other neurodegenerative diseases. We aim to identify targets for new therapeutic strategies, including neuromodulation surgery.
Main Research is clinical interventions for ADHD, OCD and Tourette Syndrome, and research in outreach programmes. Both non-pharmacological interventions for children with ADHD, cognitive behavioural therapy for OCD and Tourette's Syndrome as well as add-on projects on neuropsychological aspects and genetics are in focus.
We develop, implement and validate neurophysiological methods in clinical practice. Main topics: automated seizure detection, electromagnetic source imaging, nerve and muscle excitability and ultrasound. See also: www.en.auh.dk/departments/department-of-clinical-neurophysiology/publications/.
Neurogenic orthostatic hypotension is a red flag for a significant underlying disease. Our focus is at present on Parkinsons disease, diabetes, and TTR-amyloidosis. We can evaluate peripheral small fibre sensory and autonomic function and monitor the cardiovagal and cardiovascular adrenergic system.
Methodology for electrodiagnosis of neuromuscular diseases with special emphasis on diagnostic criteria for amyotrophic lateral sclerosis. The use of quantitative neurophysiological methods including electroencephalographic reactivity for prognostication of comatose patients.
Our work concerns the use of Gottingen minipig as a model animal in neurosurgery and neuroscience. In my research, I focus on studying the anatomy and histology of the minipig brain, as well as describing brain tissue reaction in various disease models and after using different treatment modalities.
Our research focuses on the molecular correlates of treatment response to rapid acting antidepressants with particular emphasis on ketamine and psilocybin. We are also focusing on protein-protein interactions regulating the trafficking and function of the sortilin receptor and the serotonin transporter.
Our research group conducts basic science and clinical consciousness research. In our current main line of research, we use MRI based to build neuroarchitectural models with the aim of providing exhaustive explanations for a range of phenomena in conscious perception and related cognitive functions.
My research partly focuses on cognitive impairment in primarily neurodegenerative diseases and partly on the highly interdisciplinary field of human-technology interaction. The latter spans from Internet-delivered intervention research to basic research into social cognition and implicit biases in relation to interactions with social robots.
We develop novel biomarkers for PET imaging. A current focus is imaging neuropeptides such as oxytocin and neuropeptide Y for the first time in human. We couple this work with analysis of plasma hormones. We apply these methods to study effects of food and oral contraceptives on brain and behaviour.
We develop methods to measure brain changes based on MRI and other imaging modalities that allow us to understand disease processes and quantify their progression in various brain disorders. We have a particular focus on neurodegenerative diseases, such as Alzheimer, Parkinson, and multiple sclerosis.
Our research is primarily on various clinical aspects of the psychopathology of mood disorders, electroconvulsive therapy, psychopharmacology, and the association with physical illness.
Neuromarkers helping in a clinical seeting to estimat neuronal damage are most needed. E.g. neurofilaments are proteins selectively expressed in the cytoskeleton of neurons, and increased levels are a marker of axonal damage. We investigate the role and need in various nerve injuries and diseases.
I do research on social cognition which is the ability to interact socially, e.g. to infer the feelings and intentions of other people. I investigate ways to assess and treat social cognitive deficits in people with schizophrenia and in autism spectrum disorders.
Our aim is to create a wearable seizure alarm for patients with epilepsy. The alarm system is based on heart rate variability measured with wearable electrocardiography (ECG). The seizure alarm will be a vital asset for patients enabling caregivers to take necessary precautions during seizures.
Our research focuses on the investigation of pathogenic processes in Parkinson’s disease (PD) using experimental animal models and human patient tissue. We employ histology, behavioral testing of PD rodent models, PET/MRI imaging and tracer studies to evaluate disease progression.